Pacer Advisors Inc. Lowers Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Pacer Advisors Inc. lowered its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 7.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 59,976 shares of the company's stock after selling 4,826 shares during the quarter. Pacer Advisors Inc.'s holdings in GE HealthCare Technologies were worth $4,689,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of GEHC. Quent Capital LLC raised its stake in GE HealthCare Technologies by 18.4% during the third quarter. Quent Capital LLC now owns 766 shares of the company's stock valued at $72,000 after buying an additional 119 shares during the last quarter. Greenleaf Trust raised its stake in GE HealthCare Technologies by 1.7% during the third quarter. Greenleaf Trust now owns 7,619 shares of the company's stock valued at $715,000 after buying an additional 124 shares during the last quarter. Westside Investment Management Inc. raised its stake in GE HealthCare Technologies by 32.0% during the third quarter. Westside Investment Management Inc. now owns 516 shares of the company's stock valued at $48,000 after buying an additional 125 shares during the last quarter. Quarry LP raised its stake in GE HealthCare Technologies by 28.3% during the second quarter. Quarry LP now owns 594 shares of the company's stock valued at $46,000 after buying an additional 131 shares during the last quarter. Finally, Harbour Investments Inc. raised its stake in GE HealthCare Technologies by 4.3% during the third quarter. Harbour Investments Inc. now owns 3,164 shares of the company's stock valued at $297,000 after buying an additional 131 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares of the company's stock, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.27% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Stock Performance

Shares of GEHC traded down $0.79 during trading hours on Monday, hitting $87.51. The stock had a trading volume of 2,138,966 shares, compared to its average volume of 2,674,285. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. GE HealthCare Technologies Inc. has a 12 month low of $72.61 and a 12 month high of $94.55. The firm has a market capitalization of $39.98 billion, a PE ratio of 24.04, a PEG ratio of 2.92 and a beta of 1.14. The stock has a fifty day moving average price of $82.87 and a 200 day moving average price of $85.04.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a $0.035 dividend. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. This is a positive change from GE HealthCare Technologies's previous quarterly dividend of $0.03. GE HealthCare Technologies's payout ratio is presently 3.85%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on GEHC. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of "Moderate Buy" and an average price target of $96.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.